Olema Pharmaceuticals, Inc.
OLMA
Rank in Stocks
#10812
Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical... Olema Pharmaceuticals, Inc., a biopharmaceutical enterprise in the clinical development stage, is dedicated to discovering, advancing, and commercializing therapeutic solutions for women's oncology. Headquartered in San Francisco, California, the company was established in 2006 and rebranded from CombiThera, Inc. in March 2009. Its most promising investigational compound, OP-1250, an estrogen receptor (ER) antagonist and selective ER degrader, is presently undergoing Phase 1/2 clinical evaluations. This drug candidate is being assessed for its efficacy in managing recurrent, locally advanced, or metastatic breast cancer that expresses estrogen receptors but is negative for human epidermal growth factor receptor 2.
Share Price
$7.36
Last synced: 2026-11-09
Market Cap
$643.98M
Change (1 day)
0.41%
Change (1 year)
-8.68%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Olema Pharmaceuticals, Inc. (OLMA)
Category
Healthcare
EPS for Olema Pharmaceuticals, Inc. (OLMA)
EPS as of June 2026 TTM: $-2.12
According to Olema Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $-2.12. At the end of 2025 the company had an EPS of $-1.87, an increase over its 2024 EPS of $-2.20.
EPS history for Olema Pharmaceuticals, Inc. from 2018 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-2.12 | 13.37% |
| 2025 | $-1.87 | -15.00% |
| 2024 | $-2.20 | 2.80% |
| 2023 | $-2.14 | -18.32% |
| 2022 | $-2.62 | 46.37% |
| 2021 | $-1.79 | 208.62% |
| 2020 | $-0.58 | 427.27% |
| 2019 | $-0.11 | -31.25% |
| 2018 | $-0.16 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -838.68% |
US
|
|
| $-7.07 | 233.49% |
US
|
|
| $-5.29 | 149.53% |
AU
|
|
| $12.88 | -707.55% |
BE
|
|
| $21.56 | -1,116.98% |
NL
|
Questions about Olema Pharmaceuticals, Inc.'s earnings per share (EPS)
What is Olema Pharmaceuticals, Inc.'s earnings per share (EPS)?
Olema Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $-2.12, as of Jun 2026.
What was Olema Pharmaceuticals, Inc.'s earnings per share (EPS) in 2025?
In 2025, Olema Pharmaceuticals, Inc.'s earnings per share (EPS) was $-1.87, compared with $-2.20 in 2024.
How has Olema Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Olema Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2020 ($-0.58) and lowest in 2022 ($-2.62).
How does Olema Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?
Olema Pharmaceuticals, Inc.'s earnings per share (EPS) ($-2.12) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.